Primary Site >> Stomach Cancer
Gene >> FOXK2
| 1. | |||||||||||
| Journal: | Br J Cancer. 2005 Jun 20;92(12):2122-8. | ||||||||||
| Title: | Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer. | ||||||||||
| Author: | Moehler, M|Eimermacher, A|Siebler, J|Hohler, T|Wein, A|Menges, M|Flieger, D|Junginger, T|Geer, T|Gracien, E|Galle, P R|Heike, M | ||||||||||
| PMID: | 15942629 | ||||||||||
| 2. | |||||||||||
| Journal: | Cancer Treat Rev. 2007 Jun;33(4):315-24. | ||||||||||
| Title: | Chemotherapy of advanced gastric cancer. | ||||||||||
| Author: | Rivera, Fernando|Vega-Villegas, M Eugenia|Lopez-Brea, Marta F | ||||||||||
| PMID: | 17376598 | ||||||||||
| 3. | |||||||||||
| Journal: | Ann Oncol. 2008 Apr;19(4):729-33. | ||||||||||
| Title: | Randomized phase II study of irinotecan, leucovorin and 5-fluorouracil (ILF) versus cisplatin plus ILF (PILF) combination chemotherapy for advanced gastric cancer. | ||||||||||
| Author: | Park, S H|Nam, E|Park, J|Cho, E K|Shin, D B|Lee, J H|Lee, W K|Chung, M|Lee, S I | ||||||||||
| PMID: | 18083691 | ||||||||||
| 4. | |||||||||||
| Journal: | Ai Zheng. 2009 Oct;28(10):1108-13. | ||||||||||
| Title: | [Progress in chemotherapy for advanced gastric cancer]. | ||||||||||
| Author: | Xu, Rui-Hua|Teng, Kai-Yuan | ||||||||||
| PMID: | 19799823 | ||||||||||
| 5. | |||||||||||
| Journal: | Mol Med Rep. 2018 Sep 7. | ||||||||||
| Title: | Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer. | ||||||||||
| Author: | Liu, Xi|Wei, Xiaodong|Niu, Wei|Wang, Dong|Wang, Bo|Zhuang, Hao | ||||||||||
| PMID: | 30221666 | ||||||||||